ConductScience.org, home

Paper34412685

Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients.

Marofi F and 15 others. Stem Cell Res Ther, 2021. Cited by 75 papers, by iCite.

Cite this record

ConductScience Library. Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients. Papers, record 34412685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34412685

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients.
PubMed
Journal
Stem Cell Res Ther
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
75
iCite
Relative citation ratio, by iCite
4.2
iCite
Revised in PubMed
2023-06-07
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marofi FFaroogh
2Rahman HSHeshu Sulaiman
3Al-Obaidi ZMJZaid Mahdi Jaber
4Jalil ATAbduladheem Turki
5Abdelbasset WKWalid Kamal
6Suksatan WWanich
7Dorofeev AEAleksei Evgenievich
8Shomali NNavid
9Chartrand MSMax Stanley
10Pathak YYashwant
11Hassanzadeh AAli
12Baradaran BBehzad
13Ahmadi MMajid
14Saeedi HHossein
15Tahmasebi SSafa
16Jarahian MMostafa

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, Myeloid, AcuteMajor topic
Receptors, Chimeric AntigenMajor topic
Humans
Immunotherapy
Immunotherapy, Adoptive
T-Lymphocytes

References192

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111222367A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease.Blood2001https://conductscience.org/library/papers/11222367PubMed
229385370Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.N Engl J Med2018https://conductscience.org/library/papers/29385370PubMed
315931392Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.J Clin Invest2005https://conductscience.org/library/papers/15931392PubMed
4259390634-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.Nat Med2015https://conductscience.org/library/papers/25939063PubMed
530275568Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell.Nat Med2018https://conductscience.org/library/papers/30275568PubMed
611021753The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.Leukemia2000https://conductscience.org/library/papers/11021753PubMed
724876563Current concepts in the diagnosis and management of cytokine release syndrome.Blood2014https://conductscience.org/library/papers/24876563PubMed
83960109Retrovirus-mediated transfer and expression of drug resistance genes in human haematopoietic progenitor cells.Nature1986https://conductscience.org/library/papers/3960109PubMed
917108138CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.Cancer Res2006https://conductscience.org/library/papers/17108138PubMed
1017227830CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy.Blood2007https://conductscience.org/library/papers/17227830PubMed
1129856956Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.Cell2018https://conductscience.org/library/papers/29856956PubMed
127053567Liposomes as gene carriers: efficient transformation of mouse L cells by thymidine kinase gene.Science1982https://conductscience.org/library/papers/7053567PubMed
1322553251Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.Sci Transl Med2012https://conductscience.org/library/papers/22553251PubMed
1428666104Hematopoietic stem cell transplantation for acute myeloid leukemia: A review.Hematol Oncol Stem Cell Ther2017https://conductscience.org/library/papers/28666104PubMed
1517609428The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells.Blood2007https://conductscience.org/library/papers/17609428PubMed
1624777247T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.Cancer Immunol Res2013https://conductscience.org/library/papers/24777247PubMed
1731723825CAR T Cell Toxicity: Current Management and Future Directions.Hemasphere2019https://conductscience.org/library/papers/31723825PubMed
1828029927Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.N Engl J Med2016https://conductscience.org/library/papers/28029927PubMed
1923831595Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia.Mol Ther2013https://conductscience.org/library/papers/23831595PubMed
2030809033Early and late hematologic toxicity following CD19 CAR-T cells.Bone Marrow Transplant2019https://conductscience.org/library/papers/30809033PubMed

See all 192 referencesDownload CSV of references

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.

PMIDTitleJournalYearIn PapersSource
42767771Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia, version 2.0.J Immunother Cancer2026https://conductscience.org/library/papers/42767771PubMed
42592083Tunable universal OR-gated CAR T cells for AML.iScience2026https://conductscience.org/library/papers/42592083PubMed
42200022Efficacy and safety of FLT3 inhibitors for acute myeloid leukemia: a network meta-analysis.Front Oncol2026https://conductscience.org/library/papers/42200022PubMed
41131610CAR-T and CAR-NK cell therapies in AML: breaking barriers and charting the future.J Transl Med2025https://conductscience.org/library/papers/41131610PubMed
40779041Exosome-Based Therapies in Dermatology.Aesthetic Plast Surg2025https://conductscience.org/library/papers/40779041PubMed
40649828Targets for CAR Therapy in Multiple Myeloma.Int J Mol Sci2025https://conductscience.org/library/papers/40649828PubMed
40583406NKT cells-a generalist in disease treatment and a new key to unlock immunotherapy.Immunotherapy2025https://conductscience.org/library/papers/40583406PubMed
40564892The Problem of Molecular Target Choice for CAR-T Cells in Acute Myeloid Leukemia Therapy.Int J Mol Sci2025https://conductscience.org/library/papers/40564892PubMed
40557469CD38-Targeting Peptide Vaccine Ameliorates Aging-Associated Phenotypes in Mice.Aging Cell2025https://conductscience.org/library/papers/40557469PubMed
40425009CD97-directed CAR-T cells with enhanced persistence eradicate acute myeloid leukemia in diverse xenograft models.Cell Rep Med2025https://conductscience.org/library/papers/40425009PubMed
40144774Recent advances of CAR-T cells in acute myeloid leukemia.Ther Adv Hematol2025https://conductscience.org/library/papers/40144774PubMed
39877157Stem cell status and prognostic applications of cuproptosis-associated lncRNAs in acute myeloid leukemia.Front Cell Dev Biol2024https://conductscience.org/library/papers/39877157PubMed
39833547CRISPR knock-in of a chimeric antigen receptor into GAPDH 3'UTR locus generates potent B7H3-specific NK-92MI cells.Cancer Gene Ther2025https://conductscience.org/library/papers/39833547PubMed
38712978Recent advances in CAR-T cell therapy for acute myeloid leukaemia.J Cell Mol Med2024https://conductscience.org/library/papers/38712978PubMed
38541635Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression.Life (Basel)2024https://conductscience.org/library/papers/38541635PubMed
38213150Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies.Recent Pat Anticancer Drug Discov2024https://conductscience.org/library/papers/38213150PubMed
38151649Gastric cancer and mesenchymal stem cell-derived exosomes: from pro-tumorigenic effects to anti-cancer vehicles.Arch Pharm Res2024https://conductscience.org/library/papers/38151649PubMed
38090582Broadening the horizon: potential applications of CAR-T cells beyond current indications.Front Immunol2023https://conductscience.org/library/papers/38090582PubMed
38048594A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML.Blood2024https://conductscience.org/library/papers/38048594PubMed
38021600Clinical Trials on Cellular Therapy for Children and Adolescents With Cancer: A 15-Year Trend in the United States.Cureus2023https://conductscience.org/library/papers/38021600PubMed

See all 46 cited byDownload CSV of cited by

Genes88

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADGRE230817PubTator's text mininghttps://conductscience.org/library/genes/30817NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
CA9768PubTator's text mininghttps://conductscience.org/library/genes/768NCBI Gene
CARS1833PubTator's text mininghttps://conductscience.org/library/genes/833NCBI Gene
CARTPT9607PubTator's text mininghttps://conductscience.org/library/genes/9607NCBI Gene
CASP9842PubTator's text mininghttps://conductscience.org/library/genes/842NCBI Gene
CCL16346PubTator's text mininghttps://conductscience.org/library/genes/6346NCBI Gene
CCR11230PubTator's text mininghttps://conductscience.org/library/genes/1230NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD22933PubTator's text mininghttps://conductscience.org/library/genes/933NCBI Gene
CD247919PubTator's text mininghttps://conductscience.org/library/genes/919NCBI Gene
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD33945PubTator's text mininghttps://conductscience.org/library/genes/945NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene

See all 88 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34412685

GET https://conductscience.org/api/papers/v1/34412685/references?page=2